Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae - a case-control study from Qatar

被引:7
|
作者
Naushad, Vamanjore A. [1 ,4 ,5 ]
Purayil, Nishan K. [1 ,4 ,5 ]
Wilson, Godwin J. [2 ,5 ]
Chandra, Prem [3 ]
Joseph, Prakash [1 ,4 ]
Khalil, Zahida [1 ,4 ]
Zahid, Muhammad [1 ,5 ]
Kayakkool, Muhammed K. [1 ,4 ,5 ]
Shaik, Noorjahan [1 ]
Ayari, Basma [1 ,5 ]
Chalihadan, Sajid [1 ]
Elmagboul, Emad Basheir I. [2 ]
Doiphode, Sanjay H. [2 ,5 ]
机构
[1] Hamad Gen Hosp, Gen Internal Med Dept, Hamad Med Corp, Doha, Qatar
[2] Hamad Med Corp, Dept Microbiol, Doha, Qatar
[3] Hamad Med Corp, Med Res Ctr, Doha, Qatar
[4] Qatar Univ, Coll Med, Doha, Qatar
[5] Weill Cornell Med, Ar Rayyan, Qatar
来源
IJID REGIONS | 2022年 / 3卷
关键词
ESBL; Urinary tract infections; Extended-spectrum beta-lactamase; Antibiotics; ESCHERICHIA-COLI; RISK-FACTORS; RESISTANCE TRENDS; COMMUNITY; SUSCEPTIBILITY; PREVALENCE; BACTERIA; CARE;
D O I
10.1016/j.ijregi.2022.05.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Community-acquired urinary tract infection (UTI) is the most common infection caused by extended -spectrum beta-lactamase (ESBL)-producing organisms. Aim: to estimate the prevalence of ESBL-UTI in adults and to identify potential risk factors that may predispose to ESBL-UTI. Methods: A retrospective study involving adult patients with UTI caused by ESBL-producing organisms was undertaken. Patients with UTI caused by non-ESBL-producing organisms represented the control group. Results: In total, 1100 UTI isolates were included in the study, 277 of which were ESBL positive. The prevalence rate was 25.2%. The mean age of patients was 55.87 years. On univariate analysis, prior history of UTI or ESBL-UTI, invasive urological procedure within preceding 3 months, hospital admission within preceding 3 months, and exposure to antibiotics were found to be significant risk factors for ESBL-UTI. On multi-variate analysis, use of cephalosporins [adjusted odds ratio (OR) 1.61, P = 0.048], previous ESBL-UTI (adjusted OR 2.67, P < 0.001), and invasive urological procedure in the preceding year (adjusted OR 1.61, P = 0.022) were found to be independent risk factors for ESBL-UTI. Conclusions: In Qatar, the prevalence of ESBL-UTI in adults is modest. Recent exposure to antibiotics, previous ESBL-UTI and invasive urological procedures were found to be independent risk factors for ESBL-UTI.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 50 条
  • [21] Detection of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in vegetables, soil and water of the farm environment in Tunisia
    Ben Said, Leila
    Jouini, Ahlem
    Klibi, Naouel
    Dziri, Raoudha
    Andrea Alonso, Carla
    Boudabous, Abdellatif
    Ben Siama, Karim
    Torres, Carmen
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2015, 203 : 86 - 92
  • [22] Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study
    Basima A. Almomani
    Wail A. Hayajneh
    Abeer M. Ayoub
    Mera A. Ababneh
    Miral A. Al Momani
    Infection, 2018, 46 : 495 - 501
  • [23] A toolkit for the management of infection or colonization by extended-spectrum beta-lactamase producing Enterobacteriaceae in Italy: implementation and outcome of a European project
    Mondain, V.
    Secondo, G.
    Guttmann, R.
    Ferrea, G.
    Dusi, A.
    Giacomini, M.
    Courjon, J.
    Pradier, C.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (05) : 987 - 992
  • [24] Risk factors of extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia in Thai emergency department: a retrospective case-control study
    Musikatavorn, Khrongwong
    Chumpengpan, Chatgaew
    Sujinpram, Chaita
    ASIAN BIOMEDICINE, 2011, 5 (01) : 129 - 138
  • [25] Fecal Carriage of Extended-spectrum Beta-lactamase and AmpC Beta-lactamase-producing Enterobacteriaceae in a Turkish Community
    Hazirolan, G.
    Mumcuoglu, I.
    Altan, G.
    Ozmen, B. B.
    Aksu, N.
    Karahan, Z. C.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2018, 21 (01) : 81 - 86
  • [26] Diagnosis and Management of Infections Caused by Enterobacteriaceae Producing Extended-Spectrum beta-Lactamase
    Amelia, Audrey
    Nugroho, Agung
    Harijanto, Paul N.
    ACTA MEDICA INDONESIANA, 2016, 48 (02) : 156 - 166
  • [27] A clinical prediction tool for extended-spectrum β-lactamase-producing Enterobacteriaceae urinary tract infection
    Liu, Hui
    Qiu, Suishan
    Chen, Minghao
    Lyu, Jun
    Yu, Guangchao
    Xue, Lianfang
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [28] Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial - Escherichia coli infection in China
    Shi, Huiqing
    Sun, Fengjun
    Chen, Jianhong
    Ou, Qianyi
    Feng, Wei
    Yong, Xiaolan
    Xia, Peiyuan
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2015, 14
  • [29] Urinary Tract Infections With Extended-spectrum-β-lactamase-producing Bacteria Case-control Study
    Amin, Omayma
    Prestel, Christopher
    Gonzalez, Mark D.
    Lyon, Tabitha
    Shane, Andi
    Jaggi, Preeti
    Tippett, Ashley
    Yildirim, Inci
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (03) : 211 - 216
  • [30] Enterobacteriaceae producing extended spectrum beta-lactamase: Epidemiology, risk factors, and prevention
    Vodovar, D.
    Marcade, G.
    Raskine, L.
    Malissin, I.
    Megarbane, B.
    REVUE DE MEDECINE INTERNE, 2013, 34 (11): : 687 - 693